News
News and Updates from Phoenix Children's
- Home /
- News
- The new space, which replaces Phoenix Children’s existing NICU, is Arizona's only Level IV NICU as designated by the American Academy of Pediatrics, indicating the highest level of care available for the most complex neonatal conditions. In addition to providing high-quality medical care, the new space was designed to enhance patient family comfort.
- Research conducted at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine — Phoenix shows normalizing cancer tumor vessels and alleviating low oxygen levels in the tumor microenvironment can improve the effectiveness of chemotherapy treatment in lung cancer, according to a paper published in EMBO Molecular Medicine.
- Dr. Hauptman, who assumes his post in June, is a highly regarded pediatric neurosurgeon, researcher and professor. A practicing surgeon for more than 10 years, Dr. Hauptman offers unique expertise in the surgical management of pediatric epilepsy, removal of tumors in eloquent brain regions and treatment of congenital brain and spine anomalies in infants and young children.
- On May 1, Phoenix Children’s will unveil a 407-foot commissioned mural that has transformed a heavily trafficked corridor into a captivating and exciting journey for children and their families. Nearly two years in the making, the art installation, called “Wonder And Wander” brings vibrant colors and imaginative designs to a major hospital hallway through which 70,000 children are transported each year.
- In his new role, Dr. Patel leads four of Phoenix Children’s eight clinical centers. He also oversees hospitalist medicine, mental and behavioral health, and Phoenix Children’s Pediatrics practices. Beyond his clinical responsibilities, Dr. Patel is now part of the health system’s Executive Physician Leadership team and the Phoenix Children’s Medical Group Governance Council.
- In a move that strengthens the medical leadership of Phoenix Children’s, the health system today announced a new chief medical officer (CMO) as well as the expansion of the CMO office to include two associate CMOs.
- Pediatric patients who have severe forms of lung disease associated with respiratory failure often need transplantable lung tissues and this study proves generating transplantable lungs from stem cells using large animals as bioreactors is possible.
- As an accomplished surgeon, leader and professor, Dr. Fraser will be tasked with ensuring pediatric patients receive high-quality, family-centered surgical care whether they’re receiving treatment at Phoenix Children’s Hospital — Thomas Campus, a new site of service in the west or east Valley or one of the health system’s outpatient surgery centers.
- An internationally renowned research scientist at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded a multimillion-dollar grant from the National Institutes of Health (NIH) to develop new treatment methods for lung disease in premature infants.
- This prestigious recognition program acknowledges and honors individuals who were chosen by their peers and the senior editors of Modern Healthcare as the most influential figures in the industry in terms of leadership and impact.